These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
295 related items for PubMed ID: 22525606
1. Bisphosphonate-related osteonecrosis of the jaws--a review. Kühl S, Walter C, Acham S, Pfeffer R, Lambrecht JT. Oral Oncol; 2012 Oct; 48(10):938-947. PubMed ID: 22525606 [Abstract] [Full Text] [Related]
3. The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws. Carlson ER, Basile JD. J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):85-95. PubMed ID: 19371819 [Abstract] [Full Text] [Related]
4. Incidence of bisphosphonate-related osteonecrosis of the jaw in consideration of primary diseases and concomitant therapies. Assaf AT, Smeets R, Riecke B, Weise E, Gröbe A, Blessmann M, Steiner T, Wikner J, Friedrich RE, Heiland M, Hoelzle F, Gerhards F. Anticancer Res; 2013 Sep; 33(9):3917-24. PubMed ID: 24023329 [Abstract] [Full Text] [Related]
5. Comparison of the prognosis of bisphosphonate-related osteonecrosis of the jaw caused by oral and intravenous bisphosphonates. Shintani T, Hayashido Y, Mukasa H, Akagi E, Hoshino M, Ishida Y, Hamana T, Okamoto K, Kanda T, Koizumi K, Yoshioka Y, Tani R, Toratani S, Okamoto T. Int J Oral Maxillofac Surg; 2015 Jul; 44(7):840-4. PubMed ID: 25861974 [Abstract] [Full Text] [Related]
6. A study of 225 patients on bisphosphonates presenting to the bisphosphonate clinic at King's College Hospital. Taylor T, Bryant C, Popat S. Br Dent J; 2013 Apr; 214(7):E18. PubMed ID: 23579162 [Abstract] [Full Text] [Related]
7. Oral bisphosphonates as a cause of bisphosphonate-related osteonecrosis of the jaws: clinical findings, assessment of risks, and preventive strategies. Assael LA. J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):35-43. PubMed ID: 19371813 [Abstract] [Full Text] [Related]
11. What impact do systemically administrated bisphosphonates have on oral implant therapy? A systematic review. Madrid C, Sanz M. Clin Oral Implants Res; 2009 Sep; 20 Suppl 4():87-95. PubMed ID: 19663954 [Abstract] [Full Text] [Related]
14. Database analysis of the risk factors of bisphosphonate-related osteonecrosis of the jaw in Hungarian patients. Veszelyné Kotán E, Bartha-Lieb T, Parisek Z, Meskó A, Vaszilkó M, Hankó B. BMJ Open; 2019 May 22; 9(5):e025600. PubMed ID: 31122970 [Abstract] [Full Text] [Related]
17. Intravenous bisphosphonate therapy and bisphosphonate-related osteonecrosis of the jaws. Dodson TB. J Oral Maxillofac Surg; 2009 May 22; 67(5 Suppl):44-52. PubMed ID: 19371814 [Abstract] [Full Text] [Related]
18. Bisphosphonate-related osteonecrosis of the jaws: study of the staging system in a series of clinical cases. Bagan JV, Hens-Aumente E, Leopoldo-Rodado M, Poveda-Roda R, Bagan L. Oral Oncol; 2012 Aug 22; 48(8):753-7. PubMed ID: 22401869 [Abstract] [Full Text] [Related]